グリベンクラミド (Synonyms: Glibenclamide; Glyburide)

Name: Glibenclamide
Brand: MedChemExpress
SKU: HY-15206
Rating: 5.0 (27 reviews)

製品番号: HY-15206 純度: 99.83%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Glibenclamide (Glyburide) is an orally active ATP-sensitive K⁺ channel (K_ATP) inhibitor and can be used for the research of diabetes and obesity. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of K_ATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR). Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. Glibenclamide can induce autophagy.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 10238-21-8

容量	価格（税別）	在庫状況	数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	USD 60	在庫あり	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	USD 60	在庫あり	Estimated Time of Arrival: December 31
Solid
500 mg	$55	在庫あり	Estimated Time of Arrival: December 31
1 g	$66	在庫あり	Estimated Time of Arrival: December 31
5 g	$92	在庫あり	Estimated Time of Arrival: December 31
10 g		お問い合わせ
50 g		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 27 publication(s) in Google Scholar

Other Forms of Glibenclamide:

Glyburide-d₁₁ 在庫あり
Glyburide-d₃ 在庫あり
Glibenclamide-¹³C₆ お問い合わせ
Glibenclamide potassium お問い合わせ
Glibenclamide (Standard) お問い合わせ

顧客検証

ELISA

In Vivo Efficacy Study

Histological Imaging/Staining

IHC

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jan 31;16(1):1212. [Abstract]; Immunoblots of DARTS assay that verified the binding of glyburide (50 µM, 24 h) to IFI16 in U251 cells (n = 3). An unpaired two-tailed t-test was applied. Data are presented as mean ± SD.

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jan 31;16(1):1212. [Abstract]; Time response of the mice weight after implantation of U251R cells, on average, the xenograft was locally irradiated with 15 Gy of X-rays, and the mice were administered intragastrically with 1 mg/kg glyburide 2 h before irradiation (N = 5 per group). Data are presented as mean ± SD.

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jan 31;16(1):1212. [Abstract]; Representative MRI images of U251R xenografts by T2-weighted MRI at 10-day and 20-day after cell implantation, the whole mount HE-stained brain sections of mice (administered intragastrically with 1 mg/kg glyburide 2 h before irradiation).

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jan 31;16(1):1212. [Abstract]; Glyburide (administered intragastrically with 1 mg/kg glyburide 2 h before irradiation). The positive area of IFI16, HMOX1, and GPX4 in the U251R tumor tissues (N = 5 per group). An unpaired two-tailed t-test was applied. Data are presented as mean ± SD. “n” means the number of individual experiments. “N” represents the number of mice analyzed.

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Pharmacol Res. 2020 Mar;153:104679. [Abstract]; Glucose-dependent insulinotropic effects of CPU025 in MIN6 cells. MIN6 cells were treated with 2 or 25 mM glucose in the absence or presence of Glibenclamide (3 μM).

: Glibenclamide purchased from MedChemExpress. Usage Cited in: Front Cell Dev Biol. 2020 May 12;8:269. [Abstract]; The inhibition of HSP70 releasing by Glibenclamide suppresses morphine-induced ER stress and the phosphorylation of PKA and NR-1. Glibenclamide (200 μM) inhibits the decrease of intracellular HSP70 caused by morphine in SH-SY5Y cells.

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

Glibenclamide (Glyburide) is an orally active ATP-sensitive K⁺ channel (K_ATP) inhibitor and can be used for the research of diabetes and obesity^[1]. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of K_ATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR)^[3]. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability^[4]. Glibenclamide can induce autophagy^[5].

IC₅₀ & Target

K_ATP^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
CHO	IC₅₀	0.0043 3 Compound: 6 (glyburide)	Inhibition of human SUR1/Kir6.2 expressed in CHO cells Inhibition of human SUR1/Kir6.2 expressed in CHO cells	[PMID: 11356099]
CHO	IC₅₀	15 3 Compound: glibenclamide	Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay	[PMID: 21397997]
CHO	IC₅₀	15 3 Compound: glibenclamide	Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay	[PMID: 21397997]
HEK293	IC₅₀	1.4 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate	[PMID: 22587986]
CHO	IC₅₀	0.0043 3 Compound: 6 (glyburide)	Inhibition of human SUR1/Kir6.2 expressed in CHO cells Inhibition of human SUR1/Kir6.2 expressed in CHO cells	[PMID: 11356099]
CHO	IC₅₀	15 3 Compound: glibenclamide	Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay Inhibition of wild type CFTR expressed in CHO cells by [125I]iodide efflux assay	[PMID: 21397997]
HEK293	IC₅₀	2.2 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate	[PMID: 22587986]
HEK293	IC₅₀	1.4 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate	[PMID: 22587986]
HEK293	IC₅₀	21 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate	[PMID: 22587986]
HEK293	IC₅₀	21 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate	[PMID: 22587986]
HEK293	IC₅₀	2.2 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate	[PMID: 22587986]
INS-1E	EC₅₀	0.003 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose	[PMID: 24484900]
INS-1E	EC₅₀	0.007 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose	[PMID: 24484900]
INS-1E	EC₅₀	0.007 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose	[PMID: 24484900]
INS-1E	EC₅₀	0.003 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose	[PMID: 24484900]
Mesenchymal stem cells	EC₅₀	2.8 3 Compound: GLI	Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA	[PMID: 35172097]
Mesenchymal stem cells	EC₅₀	2.8 3 Compound: GLI	Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA	[PMID: 35172097]
U-373MG ATCC	IC₅₀	> 100 3 Compound: Glibenclamide	Growth inhibition of human U373 cells after 72 hrs by MTT assay Growth inhibition of human U373 cells after 72 hrs by MTT assay	[PMID: 22809560]
Oocyte	IC₅₀	0.22 3 Compound: 6 (glyburide)	Inhibition of human SUR2A/Kir6.2 expressed in Xenopus oocytes Inhibition of human SUR2A/Kir6.2 expressed in Xenopus oocytes	[PMID: 11356099]
Sf21	IC₅₀	5.3 3 Compound: Glibenclamide	Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake	[PMID: 21965623]
Sf21	IC₅₀	2.8 3 Compound: Glibenclamide	Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake	[PMID: 21965623]
T-cell line	IC₅₀	1 3 Compound: 2	In vitro inhibition of Rb efflux in human T-cells; 1-10 In vitro inhibition of Rb efflux in human T-cells; 1-10	10.1016/S0960-894X(97)00163-7
U-373MG ATCC	IC₅₀	>100 3 Compound: Glibenclamide	Growth inhibition of human U373 cells after 72 hrs by MTT assay Growth inhibition of human U373 cells after 72 hrs by MTT assay	[PMID: 22809560]
HEK293	IC₅₀	1.4 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estradiol-17beta-glucuronide substrate	[PMID: 22587986]
HEK293	IC₅₀	2.2 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using pitavastatin substrate	[PMID: 22587986]
HEK293	IC₅₀	21 3 Compound: Glibenclamide	Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate Inhibition of OATP1B1 (unknown origin) expressed in HEK293 cells using estrone-3-sulfate substrate	[PMID: 22587986]
INS-1E	EC₅₀	0.003 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 5 mM glucose	[PMID: 24484900]
INS-1E	EC₅₀	0.007 3 Compound: glibenclamide	Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose Stimulation of insulin secretion in rat INS-1E cells after 1 hr by alphaLISA assay in presence of 0.1 mM glucose	[PMID: 24484900]
Mesenchymal stem cells	EC₅₀	2.8 3 Compound: GLI	Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA Induction of adiponectin secretion in human differentiated BMMSC cells measured at 5 day in the presence of IDX induction medium by ELISA	[PMID: 35172097]
Oocyte	IC₅₀	0.22 3 Compound: 6 (glyburide)	Inhibition of human SUR2A/Kir6.2 expressed in Xenopus oocytes Inhibition of human SUR2A/Kir6.2 expressed in Xenopus oocytes	[PMID: 11356099]
Sf21	IC₅₀	2.8 3 Compound: Glibenclamide	Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake	[PMID: 21965623]
Sf21	IC₅₀	5.3 3 Compound: Glibenclamide	Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake	[PMID: 21965623]
T-cell line	IC₅₀	1 3 Compound: 2	In vitro inhibition of Rb efflux in human T-cells; 1-10 In vitro inhibition of Rb efflux in human T-cells; 1-10	10.1016/S0960-894X(97)00163-7
U-373MG ATCC	IC₅₀	> 100 3 Compound: Glibenclamide	Growth inhibition of human U373 cells after 72 hrs by MTT assay Growth inhibition of human U373 cells after 72 hrs by MTT assay	[PMID: 22809560]

体外実験

Glibenclamide (Brown adipocytes; 10 μΜ; 1 day) has no effect on adipocyte differentiation. Glibenclamide (Ucp1-2A-GFP brown adipocyte) significantly increases UCP1 expression. Glibenclamide directly binds and blocks the SUR1 subunits of ATP-dependent potassium channels (K_ATP) and consequently increases insulin secretion from the pancreatic β cells^[2]. Glibenclamide interferes with mitochondrial bioenergy by permeating mitochondrial intima with Cl^- and promoting mitochondrial net Cl^-/K⁺ cotransport^[4]. Glibenclamide induced autophagy inhibits its insulin secretion-improving function in β cells^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

体内実験

Glibenclamide (2 mg/kg; p.o.) increases of insulin release and rapid drop of blood glucose level^[2].
Glibenclamide (50 μg/kg; p.o.) does not cause significant change, such as body weight or body composition^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Mice^[2]
Dosage:	2 mg/kg
Administration:	P.o.
Result:	Increased of insulin release and rapid drop of blood glucose level.

分子量

494.00

分子式

C₂₃H₂₈ClN₃O₅S

CAS 番号

10238-21-8

Appearance

Solid

Color

White to off-white

SMILES

ClC1=CC(C(NCCC2=CC=C(S(NC(NC3CCCCC3)=O)(=O)=O)C=C2)=O)=C(OC)C=C1

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : 100 mg/mL (202.43 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H₂O : < 0.1 mg/mL (insoluble)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.0243 mL	10.1215 mL	20.2429 mL
5 mM	0.4049 mL	2.0243 mL	4.0486 mL
10 mM	0.2024 mL	1.0121 mL	2.0243 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (5.06 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (5.06 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

DMSO +

Tween-80 +

Saline

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Calculation results:

Working solution concentration: mg/mL

Method for preparing stock solution: mg drug dissolved in μL DMSO (Stock solution concentration: mg/mL).

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).

Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.

If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.

純度とドキュメンテーション

純度: 99.83%

Select Batch:

データシート (275 KB) SDS (419 KB)

COA (246 KB) RP-HPLC (258 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Heo R, et al. The anti-diabetic drug trelagliptin induces vasodilation via activation of Kv channels and SERCA pumps. Life Sci. 2021;283:119868. [Content Brief]

[2]. Qiu Y, et al. Glyburide Regulates UCP1 Expression in Adipocytes Independent of KATP Channel Blockade. iScience. 2020;23(9):101446. [Content Brief]

[3]. Golstein PE, et al. P-glycoprotein inhibition by glibenclamide and related compounds. Pflugers Arch. 1999;437(5):652-660. [Content Brief]

[4]. Fernandes MA, et al. Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. J Biochem Mol Toxicol. 2004;18(3):162-169. [Content Brief]

[5]. Zhou J, et al. Glibenclamide-Induced Autophagy Inhibits Its Insulin Secretion-Improving Function in β Cells. Int J Endocrinol. 2019;2019:1265175. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	2.0243 mL	10.1215 mL	20.2429 mL	50.6073 mL
	5 mM	0.4049 mL	2.0243 mL	4.0486 mL	10.1215 mL
	10 mM	0.2024 mL	1.0121 mL	2.0243 mL	5.0607 mL
	15 mM	0.1350 mL	0.6748 mL	1.3495 mL	3.3738 mL
	20 mM	0.1012 mL	0.5061 mL	1.0121 mL	2.5304 mL
	25 mM	0.0810 mL	0.4049 mL	0.8097 mL	2.0243 mL
	30 mM	0.0675 mL	0.3374 mL	0.6748 mL	1.6869 mL
	40 mM	0.0506 mL	0.2530 mL	0.5061 mL	1.2652 mL
	50 mM	0.0405 mL	0.2024 mL	0.4049 mL	1.0121 mL
	60 mM	0.0337 mL	0.1687 mL	0.3374 mL	0.8435 mL
	80 mM	0.0253 mL	0.1265 mL	0.2530 mL	0.6326 mL
	100 mM	0.0202 mL	0.1012 mL	0.2024 mL	0.5061 mL

Glibenclamide Related Classifications

Metabolic Disease

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
製品名			カスタマ需要量 *
お名前 *			タイトル
メールアドレス *			電話番号 *
デパートメント			組纖名 *
市区町村			都道府県
国或いは地域 *
必ず会社名を記載ください。個人への返信は行いません。
備考

製品名			Lot #
お名前 *			メールアドレス *
電話番号 *			部門 *
組纖名 *			国或いは地域 *
備考

グリベンクラミド (Synonyms: Glibenclamide; Glyburide)

カスタマーレビュー

Other Forms of Glibenclamide:

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Glibenclamide Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

お名前
メール *

	Sorry, but the email address you supplied was invalid.

グリベンクラミド (Synonyms: Glibenclamide; Glyburide)

カスタマーレビュー

Other Forms of Glibenclamide:

グリベンクラミド 関連抗体

顧客検証

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

グリベンクラミド 関連抗体

Molarity Calculator

Dilution Calculator

Complete Stock Solution Preparation Table

Glibenclamide Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report

グリベンクラミド関連抗体

グリベンクラミド関連抗体